Denning DW. Echinocandin antifungal drugs. Lancet. 2003;362(9388):1142–51.

Article  CAS  PubMed  Google Scholar 

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351(14):1391–402.

Article  CAS  PubMed  Google Scholar 

van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis. 2004;39(10):1407–16.

Article  PubMed  Google Scholar 

Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomized double-blind trial. Lancet. 2007;369(9572):1519–27.

Article  CAS  PubMed  Google Scholar 

Nanri T, Iwanaga E, Fujie S, Yamada Y, Horikawa K, Mitsuya H, et al. Micafungin-induced immune hemolysis attacks. Int J Hematol. 2009;89(1):139–41.

Article  PubMed  Google Scholar 

Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009:73–79.

Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010;24(4–5):143–50.

Article  CAS  PubMed  Google Scholar 

Snapper I, Marks D, Schwartz L, Hollander L. Hemolytic anemia secondary to Mesantoin. Ann Intern Med. 1953;39(3):619–23.

Article  CAS  PubMed  Google Scholar 

Ewing DJ, Hughes CJ, Wardle DF. Methyldopa-induced autoimmune haemolytic anaemia: a report of two further cases. Guys Hosp Rep. 1968;117(2):111–8.

CAS  PubMed  Google Scholar 

Habibi B, Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure: specific involvement of red-cell antigen I. N Engl J Med. 1985;312(6):353–5.

Article  CAS  PubMed  Google Scholar 

Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood. 1987;69(4):1006–10.

Article  CAS  PubMed  Google Scholar 

Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BW. First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion. 1999;39(8):838–44.

Article  CAS  PubMed  Google Scholar 

Imam SN, Wright K, Bhoopalam N, Choudhury A. Hemolytic anemia from ceftriaxone in an elderly patient: a case report. J Am Med Dir Assoc. 2008;9(8):610–1.

Article  PubMed  Google Scholar 

Mayer B, Bartolmäs T, Yürek S, Salama A. Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. Transfus Med Hemother. 2015;42(5):333–9.

Article  PubMed  PubMed Central  Google Scholar 

Peter T, Bissinger R, Signoretto E, Mack AF, Lang F. Micafungin-induced suicidal erythrocyte death. Cell Physiol Biochem. 2016;39(2):584–95.

Article  CAS  PubMed  Google Scholar 

Yoshizawa S, Gotoh M, Kitahara T, Kiguchi T, Akahane D, Sakuta J, et al. Micafungin-induced hemolysis attack due to drug-dependent antibody persisting for more than 6 weeks. Leuk Res. 2010;34:e60–1.

Article  PubMed  Google Scholar 

Ishii H, Sato T, Ishibashi M, Yokoyama H, Saito, Tasaki T, et al. A case of immune complex type hemolytic anemia induced by initial micafungin administration. Int J Infect Dis 2022;122: 755–757.

Berentsen S. How i treat cold agglutinin disease. Blood. 2021;137:1295–303.

Article  CAS  PubMed  Google Scholar